Breast cancer Ki67 expression preoperative discrimination by DCE-MRI radiomics features

To investigate whether quantitative radiomics features extracted from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) are associated with Ki67 expression of breast cancer. In this institutional review board approved retrospective study, we collected 377 cases Chinese women who were diagnosed with invasive breast cancer in 2015. This cohort included 53 low-Ki67 expression (Ki67 proliferation index less than 14%) and 324 cases with high-Ki67 expression (Ki67 proliferation index more than 14%). A binary-classification of low- vs. high- Ki67 expression was performed. A set of 52 quantitative radiomics features, including morphological, gray scale statistic, and texture features, were extracted from the segmented lesion area. Three most common machine learning classification methods, including Naive Bayes, k-Nearest Neighbor and support vector machine with Gaussian kernel, were employed for the classification and the least absolute shrink age and selection operator (LASSO) method was used to select most predictive features set for the classifiers. Classification performance was evaluated by the area under receiver operating characteristic curve (AUC), accuracy, sensitivity and specificity. The model that used Naive Bayes classification method achieved the best performance than the other two methods, yielding 0.773 AUC value, 0.757 accuracy, 0.777 sensitivity and 0.769 specificity. Our study showed that quantitative radiomics imaging features of breast tumor extracted from DCE-MRI are associated with breast cancer Ki67 expression. Future larger studies are needed in order to further evaluate the findings.

[1]  Ewert Bengtsson,et al.  A Feature Set for Cytometry on Digitized Microscopic Images , 2003, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[2]  Alberto Costa,et al.  Gene expression profiling and prediction of response to hormonal neoadjuvant treatment with anastrozole in surgically resectable breast cancer , 2010, Breast Cancer Research and Treatment.

[3]  R. Tibshirani The lasso method for variable selection in the Cox model. , 1997, Statistics in medicine.

[4]  A. Madabhushi,et al.  Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI , 2017, Breast Cancer Research.

[5]  Hideyuki Tamura,et al.  Textural Features Corresponding to Visual Perception , 1978, IEEE Transactions on Systems, Man, and Cybernetics.

[6]  H. Iwata,et al.  Ki67 index changes, pathological response and clinical benefits in primary breast cancer patients treated with 24 weeks of aromatase inhibition , 2011, Cancer science.

[7]  Patrick Granton,et al.  Radiomics: extracting more information from medical images using advanced feature analysis. , 2012, European journal of cancer.

[8]  K. Gelmon,et al.  Ki67 in breast cancer: prognostic and predictive potential. , 2010, The Lancet. Oncology.

[9]  Serkan Ilgün,et al.  The role of ultrasonographic findings to predict molecular subtype, histologic grade, and hormone receptor status of breast cancer. , 2015, Diagnostic and interventional radiology.

[10]  D. Rimm,et al.  Quantitative assessment Ki-67 score for prediction of response to neoadjuvant chemotherapy in breast cancer , 2014, Laboratory Investigation.

[11]  Andre Dekker,et al.  Radiomics: the process and the challenges. , 2012, Magnetic resonance imaging.

[12]  I. Ellis,et al.  Breast carcinoma with basal phenotype: mammographic findings. , 2008, AJR. American journal of roentgenology.

[13]  Allen R. Tannenbaum,et al.  Localizing Region-Based Active Contours , 2008, IEEE Transactions on Image Processing.

[14]  M. Gilcrease,et al.  Ki-67 as Prognostic Marker in Early Breast Cancer: A Meta-analysis of Published Studies Involving 12 155 Patients , 2008 .

[15]  Peter Harrington,et al.  Machine Learning in Action , 2012 .

[16]  Y. Tamaki,et al.  Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer. , 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[17]  N. Paragios,et al.  Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  Mingxiang Wu,et al.  Association Between Imaging Characteristics and Different Molecular Subtypes of Breast Cancer. , 2017, Academic radiology.

[19]  H. Mukai,et al.  Survival outcome and reduction rate of Ki-67 between pre- and post-neoadjuvant chemotherapy in breast cancer patients with non-pCR , 2014, Breast Cancer Research and Treatment.